Who owns SPYGLASS PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Spyglass Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Spyglass Pharma stock

Who bought or sold SPYGLASS PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
RA Capital Management 8.0M $208M 100% Mar 2026
 View chart
NEA Management Company 7.4M $192M 100% Mar 2026
 View chart
Sands Capital Ventures 2.5M $65M 100% Mar 2026
 View chart
Samsara BioCapital 2.1M $55M 100% Mar 2026
 View chart
Vestal Point Capital 667k $17M 100% Mar 2026
 View chart
Deerfield Management Company 550k $14M 100% Mar 2026
 View chart
Millennium Management 469k $12M 100% Mar 2026
 View chart
Vanguard Capital Management 435k $11M 100% Mar 2026
 View chart
First Light Asset Management 375k $9.7M 100% Mar 2026
 View chart
Franklin Resources 300k $7.8M 100% Mar 2026
 View chart
Standard Life Aberdeen 221k $5.7M 100% Mar 2026
 View chart
BlackRock 145k $3.8M 100% Mar 2026
 View chart
Geode Capital Management 127k $3.3M 100% Mar 2026
 View chart
Monashee Investment Management 95k $2.5M 100% Mar 2026
 View chart
Vanguard Fiduciary Trust 60k $1.5M 100% Mar 2026
 View chart
Alyeska Investment Group 57k $1.5M 100% Mar 2026
 View chart
TD Asset Management 48k $1.2M 100% Mar 2026
 View chart
Ameriprise Financial 45k $1.2M 100% Mar 2026
 View chart
Bank of America Corporation 28k $726k 100% Mar 2026
 View chart
Goldman Sachs Group 19k $500k 100% Mar 2026
 View chart
Manufacturers Life Insurance Company 12k $308k 100% Mar 2026
 View chart
Squarepoint Ops 7.8k $202k 100% Mar 2026
 View chart
Vanguard Global Advisers 4.9k $128k 100% Mar 2026
 View chart
Morgan Stanley 4.2k $108k 100% Mar 2026
 View chart
Vanguard Portfolio Management 3.7k $95k 100% Mar 2026
 View chart
UBS Group 455.00 $12k 100% Mar 2026
 View chart
Royal Bank of Canada 85.00 $2.0k 100% Mar 2026
 View chart